# Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma

> **NCT01471054** · PHASE2 · TERMINATED · sponsor: **Arman Mashayekhi** · enrollment: 6 (actual)

## Conditions studied

- Macular Edema
- Cystoid Macular Edema
- Uveal Melanoma
- Radiation Maculopathy
- Radiation Retinopathy

## Interventions

- **DRUG:** Ozurdex
- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT01471054
- **Lead sponsor:** Arman Mashayekhi
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-04
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Could not enroll enough patients.
- **Last updated:** 2019-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01471054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01471054, "Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01471054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*